Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine.
about
Trial watch: Dendritic cell-based anticancer therapyHerpes simplex virus oncolytic therapy for pediatric malignanciesClassification of current anticancer immunotherapiesProgress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes.Dendritic cell fusion vaccines for cancer immunotherapy.Trial watch: Dendritic cell-based interventions for cancer therapyA microfluidic approach towards hybridoma generation for cancer immunotherapyDendritic cell-Ewing's sarcoma cell hybrids enhance antitumor immunity.Induction of antitumor immunity by semi-allogeneic and fully allogeneic electrofusion products of tumor cells and dendritic cells.Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma.Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site.Antitumor immunopreventive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinoma in vivo.The immunotherapeutic effect of dendritic cells vaccine modified with interleukin-18 gene and tumor cell lysate on mice with pancreatic carcinoma.Study on biological characters of SGC7901 gastric cancer cell-dendritic cell fusion vaccinesA cell electrofusion microfluidic chip using discrete coplanar vertical sidewall microelectrodes.Trial watch: Dendritic cell-based interventions for cancer therapy.The impact of electrical charge on the viability and physiology of dendritic cells.Trial watch: Dendritic cell-based anticancer immunotherapy.
P2860
Q27024047-C31BD814-EF5E-446C-819F-8577573A8313Q33713824-03DB550C-9302-4553-B95A-2683004581C4Q35149637-8A1ADC7A-018F-4501-B97F-7632EDA445FBQ35922431-406AB68D-0E51-4B07-8746-AAAA883F4EB4Q36150517-FF3CE08B-E552-4FD7-99D3-B10B269FEB3EQ36388529-E92C847D-598A-4258-B2C8-D6FC3842D339Q36629413-62B5658D-233F-44CF-8A8C-A28693FC6D5AQ36803613-925C5511-8084-48B3-A01B-EA3A0C65A210Q37700493-9B37C033-2D2B-4ECD-BB68-521E92805699Q39066916-3C665E31-848E-4EA0-AB72-9435025D6868Q40125045-B73C96B8-5115-4440-B229-91C62CD39D22Q40664478-BF548B45-F1A9-4545-BFFF-6C7572A94582Q41894628-E1ED874B-CA0F-4646-A201-A2A122C10201Q42726207-9273768D-9AA6-4F53-B1D3-EF764447FC2CQ42832651-569F6B76-B4ED-4594-B5F8-5710E3052B45Q42867339-1244E72F-A532-45DA-886A-4B378B9EC4E4Q46777207-46524E9B-49DE-49FE-9BFE-044F32485905Q53109846-0E5DD6BA-E571-4D6F-97B2-E3CEE92B4ABA
P2860
Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Electrofusion of a weakly immu ...... ells produces a tumor vaccine.
@en
Electrofusion of a weakly immu ...... ells produces a tumor vaccine.
@nl
type
label
Electrofusion of a weakly immu ...... ells produces a tumor vaccine.
@en
Electrofusion of a weakly immu ...... ells produces a tumor vaccine.
@nl
prefLabel
Electrofusion of a weakly immu ...... ells produces a tumor vaccine.
@en
Electrofusion of a weakly immu ...... ells produces a tumor vaccine.
@nl
P2093
P356
P1433
P1476
Electrofusion of a weakly immu ...... ells produces a tumor vaccine.
@en
P2093
P356
10.1006/CIMM.2001.1864
P577
2001-10-01T00:00:00Z